Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The open-label, Phase 2 TOPAZ (NCT03921528) trial evaluated apitegromab in 58 patients with type 2 or type 3 SMA in three study cohorts
G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment
Its Noom Med program combines GLP-1 medications with psychology lessons, coaching, and long-term habit support, making it one of the most comprehensive options available
Finally, rosiglitazone increased the expression of thyroid-specific differentiation markers ( in vitro study, under normoxic or hypoxic conditions, it was reported that rosiglitazone inhibited TC cell growth and increased NIS protein expression
US$ 27.10
US$ 28.72
US$ 22.05
